维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

15篇 您的检索式：作者名="OXNARD R"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	ALCHEMIST:Bringing genomic discovery and targeted therapies to early-stage lung cancer显示文摘	Gerber DE Oxnard GR Govindan R	2015	Clin Pharmacol Ther2015，97，5：	1
	2	Noninvasive detection of response and resistance in EGFR-mutant lung cancer using quantitative next-generation genotyping of cell-free plasma DNA显示文摘	Oxnard G R Paweletz C P Kuang Y	2014	Clin Cancer Res2014，20，6：	1
	3	New strategies in overcoming acquired resistance to epidermal growth factor re- ceptor tyrosine kinase inhibitors in lung cancer 显示文摘	Oxnard G R Arcila M E Chmielecki J	2011	Clin Cancer Res2011，17，17：	1
	4	Acquired resistance to EGFR tyrosine kinase inhibitors in EGFR-mutant lung cancer: distinct natural history of patients with tumors harboring the T?90M mutation 显示文摘	Oxnard G R Arcila M E Sima C S	2011	Clin Cancer Res2011，17，6：	1
	5	Network Structure and the Diffusion of Knowl-edge显示文摘	Cowan R Oxnard N	2004	Journal of Economic Dynamics&Control2004，28，8：	1
	6	Acquiredresistance to EGFR tyrosine kinase inhibitors in EGFR-mutant lung cancer : distinct natural history of patientswith tumors harboring the T790M mutation 显示文摘	Oxnard G R Arcila M E Sima C S ez al	2011	ClinCancer Res2011，17，6：	1
	7	Met exon 14 mutations in non-small-cell lung cancer are associated with advanced age and stage-dependent Met genomic amplification and c-Met overexpression 显示文摘	Awad M M Oxnard G R Jackman D M	2016	J Clin Oncol2016，34，7：	1
	8	Preliminary results of TATTON, a multi- ann phase Ib trial of AZD9291 combined with MEDI4736, AZD6094 or selumetinib in EGFR-mutant lung cancer显示文摘	GEOFFREY R OXNARD GR RAMALINGAM SS	2015	J Clin Oncol2015，33，15：	1
	9	Chemotherapy with Erlotinib or chemotherapy alone in advanced non-small cell lung Cancer with acquired resistance to EGFR tyrosine kinase inhibitors显示文摘	Goldberg S B Oxnard G R Digumarthy S	2013	Oncologist2013，18，11：	1
	10	Acquired resist- ance to EGFR tyrosine kinase inhibitors in EGFR - mutant lung cancer : distinct natural history of patients with tumors harboring the T790M mutation显示文摘	OXNARD G R ARCILA M E SIMA C S	2011	Clin Cancer Res2011，17，6：	1
	11	New strate-gies in overcoming acquired resistance to epidermal growthfactor receptor tyrosine kinase inhibitors in lung cancer显示文摘	Oxnard G R Arcila M E Chmielecki J	2011	Clin Cancer Res2011，17，17：	1
	12	Chemo- therapy with erlotinib or chemotherapy alone in advanced NSCLC with acquired resistance to EGFR tyrosine kinase inhibitors (TKI) 显示文摘	GOLDBER S B OXNARD R DIGUMARTHY S	2012	J Clin Oncol2012，30，15：	1
	13	Acquired resistance to EGFR tyrosine kinase inhibitors in EGFR- mutant lung cancer:Distinct natural history of patients with tumors harboring the T790M mutation 显示文摘	Oxnard G R Arcila M E Sima C S	2010	Clini- cal Cancer Research2010，17，6：	1
	14	Unsus- pected pulmonary embolism in lung cancer patients:compari- son of clinical characteristics and outcome with suspected pul- monary embolism 显示文摘	SHINAGARE A B OKAJIMA Y OXNARD G R	2012	Lung Cancer2012，78，2：	1
	15	New strategies in over- coming acquired resistance to EGFR tyrosine kinase inhibitors in lung cancer显示文摘	Oxnard G R Arcila M E Chmielecki J	2011	Clin Cancer Res2011，17，17：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费